RNA Therapy

Oncotelic Therapeutics Advances RNA Therapy for High-Unmet-Need Cancers Amid Rising Global Cancer Burden

Oncotelic Therapeutics Advances RNA Therapy for High-Unmet-Need Cancers Amid Rising Global Cancer Burden

Oncotelic Therapeutics is developing innovative RNA-based treatments for underserved cancers, addressing the growing global cancer crisis with recently completed phase 1 clinical trials.

September 17, 2025
Creative Biolabs Advances mRNA Therapeutics with Comprehensive Solutions

Creative Biolabs Advances mRNA Therapeutics with Comprehensive Solutions

Creative Biolabs is enhancing the development of mRNA therapies, offering innovative solutions that address key challenges in stability, delivery, and scalability, pivotal for treatments ranging from HIV to cancer.

June 24, 2025
Silexion Therapeutics Partners with Catalent to Advance Breakthrough KRAS Cancer Treatment

Silexion Therapeutics Partners with Catalent to Advance Breakthrough KRAS Cancer Treatment

Silexion Therapeutics is collaborating with Catalent to develop SIL204, an innovative RNA interference therapy targeting multiple KRAS mutations in pancreatic cancer, with potential to transform treatment paradigms in a $470 billion precision medicine market.

April 23, 2025